New approach methodologies in human regulatory toxicology – Not if, but how and when!

Archive ouverte

Schmeisser, Sebastian | Miccoli, Andrea | von Bergen, Martin | Berggren, Elisabet | Braeuning, Albert | Busch, Wibke | Desaintes, Christian | Gourmelon, Anne | Grafström, Roland | Harrill, Joshua | Hartung, Thomas | Herzler, Matthias | Kass, George, E.N. | Kleinstreuer, Nicole | Leist, Marcel | Luijten, Mirjam | Marx-Stoelting, Philip | Poetz, Oliver | van Ravenzwaay, Bennard | Roggeband, Rob | Rogiers, Vera | Roth, Adrian | Sanders, Pascal | Thomas, Russell, S. | Marie Vinggaard, Anne | Vinken, Mathieu | van de Water, Bob | Luch, Andreas | Tralau, Tewes

Edité par CCSD ; Elsevier -

International audience. The predominantly animal-centric approach of chemical safety assessment has increasingly come under pressure. Society is questioning overall performance, sustainability, continued relevance for human health risk assessment and ethics of this system, demanding a change of paradigm. At the same time, the scientific toolbox used for risk assessment is continuously enriched by the development of "New Approach Methodologies" (NAMs). While this term does not define the age or the state of readiness of the innovation, it covers a wide range of methods, including quantitative structure-activity relationship (QSAR) predictions, high-throughput screening (HTS) bioassays, omics applications, cell cultures, organoids, microphysiological systems (MPS), machine learning models and artificial intelligence (AI). In addition to promising faster and more efficient toxicity testing, NAMs have the potential to fundamentally transform today's regulatory work by allowing more human-relevant decision-making in terms of both hazard and exposure assessment. Yet, several obstacles hamper a broader application of NAMs in current regulatory risk assessment. Constraints in addressing repeated-dose toxicity, with particular reference to the chronic toxicity, and hesitance from relevant stakeholders, are major challenges for the implementation of NAMs in a broader context. Moreover, issues regarding predictivity, reproducibility and quantification need to be addressed and regulatory and legislative frameworks need to be adapted to NAMs. The conceptual perspective presented here has its focus on hazard assessment and is grounded on the main findings and conclusions from a symposium and workshop held in Berlin in November 2021. It intends to provide further insights into how NAMs can be gradually integrated into chemical risk assessment aimed at protection of human health, until eventually the current paradigm is replaced by an animal-free "Next Generation Risk Assessment" (NGRA).

Suggestions

Du même auteur

A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe

Archive ouverte | Marx-Stoelting, Philip | CCSD

International audience. Current approaches for the assessment of environmental and human health risks due to exposure to chemical substances have served their purpose reasonably well. Nevertheless, the systems in pl...

Metabolomics in Toxicology and Preclinical Research

Archive ouverte | Ramirez, Tzutzuy | CCSD

International audience. Metabolomics, the comprehensive analysis of metabolites in a biological system, provides detailed information about the biochemical/physiological status of a biological system, and about the ...

Innovative tools and methods for toxicity testing within PARC work package 5 on hazard assessment

Archive ouverte | de Castelbajac, Thalia | CCSD

International audience. New approach methodologies (NAMs) have the potential to become a major component of regulatory risk assessment, however, their actual implementation is challenging. The European Partnership f...

Chargement des enrichissements...